Piera Balzarini

1.4k total citations
47 papers, 995 citations indexed

About

Piera Balzarini is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Piera Balzarini has authored 47 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Piera Balzarini's work include Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Piera Balzarini is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Piera Balzarini collaborates with scholars based in Italy, United States and Belgium. Piera Balzarini's co-authors include William Vermi, Fabio Facchetti, Daniela Medicina, Vilma Pellegrini, Silvia Lonardi, Giulio Rossi, Andrea Tironi, Giovanni Bottiroli, Anna Cleta Croce and Mattia Bugatti and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Piera Balzarini

44 papers receiving 983 citations

Peers

Countries citing papers authored by Piera Balzarini

Since Specialization

Citations

This map shows the geographic impact of Piera Balzarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera Balzarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera Balzarini more than expected).

Fields of papers citing papers by Piera Balzarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera Balzarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera Balzarini. The network helps show where Piera Balzarini may publish in the future.

Co-authorship network of co-authors of Piera Balzarini

This figure shows the co-authorship network connecting the top 25 collaborators of Piera Balzarini. A scholar is included among the top collaborators of Piera Balzarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera Balzarini. Piera Balzarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription 2025 ·Acta Neuropathologica ·(unknown), Francesca Orzan, Sara Lago, Francesca De Bacco, (unknown), Manuela Cominelli, (unknown), Magdalena Gryzik, Piera Balzarini, Davide Ceresa, Daniela Marubbi, Claudio Isella, Giovanni Crisafulli, Maura Poli, Paolo Malatesta, Rossella Galli, Roberto Ronca, Alessio Zippo, Carla Boccaccio, Pietro Luigi Poliani	2
2	Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line 2023 ·Journal of Personalized Medicine ·(unknown), Magdalena Gryzik, (unknown), Manuela Cominelli, Piera Balzarini, Alberto Schreiber, Davide Mattavelli, Piero Nicolai, Francesco Doglietto, Pietro Luigi Poliani	1
3	Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88 / CD79B mutants‐enriched diffuse large B‐cell lymphomas 2022 ·European Journal of Immunology ·Vincenzo L’Imperio, (unknown), Maria Carmela Vegliante, Valeria Cancila, (unknown), Saveria Mazzara, Beatrice Belmonte, Alessandro Mangogna, Piera Balzarini, Lilia Corral, (unknown), Arianna Di Napoli, Fabio Facchetti, Fabio Pagni, Claudio Tripodo	5
4	An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens 2019 ·Haematologica ·Francesca Schieppati, Piera Balzarini, Simona Fisogni, Alessandro Re, Chiara Pagani, (unknown), (unknown), Angela Passi, Samantha Ferrari, (unknown), Chiara Bottelli, (unknown), Vilma Pellegrini, Fabio Facchetti, Giuseppe Rossi, Alessandra Tucci	15
5	slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP 2018 ·Cancer Research ·William Vermi, Alessandra Micheletti, (unknown), Cristina Tecchio, Federica Calzetti, Sara Costa, Mattia Bugatti, Stefano Calza, Claudio Agostinelli, Stefano Pileri, Piera Balzarini, Alessandra Tucci, Giuseppe Rossi, (unknown), Giuseppe Todeschini, Alberto Zamò, Fabio Facchetti, Luisa Lorenzi, Silvia Lonardi, Marco A. Cassatella	29
6	BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations 2015 ·Modern Pathology ·(unknown), Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, (unknown), Mattia Bugatti, Giulio Rossi, Bruno Murer, Mattia Barbareschi, Silvia Giuliani, Alberto Cavazza, (unknown), William Vermi, Fabio Facchetti	189
7	EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect 2015 ·Clinical Lung Cancer ·Nora Sahnane, Milo Frattini, Barbara Bernasconi, Francesco Zappa, (unknown), Luciano Wannesson, Paola Antonelli, Piera Balzarini, Fausto Sessa, Luca Mazzucchelli, Maria Grazia Tibiletti, Vittoria Martin	28
8	Ligand-Dependent Activation of EGFR in Follicular Dendritic Cells Sarcoma is Sustained by Local Production of Cognate Ligands 2013 ·Clinical Cancer Research ·William Vermi, Emanuele Giurisato, Silvia Lonardi, Piera Balzarini, Elisa Rossi, Daniela Medicina, Daniela Bosisio, Silvano Sozzani, (unknown), Claudio Doglioni, Antonio Marchetti, Giulio Rossi, Stefano Pileri, Fabio Facchetti	26
9	Simultaneous Fluorescence Immunophenotyping and Her-2/neu Genotyping (FICTION) in Breast Carcinoma Candidates to Target Therapy 2012 ·Applied immunohistochemistry & molecular morphology ·Luisa Benerini Gatta, Paolo Incardona, (unknown), Piergiovanni Grigolato, Sabrina Simoncelli, Piera Balzarini	4
10	Haematobium eggs detection in human bladder cancer and sporocysts in snail vectors: Seven cases report and a review of the Burkina Faso literature 2012 ·Pathologie Biologie ·Luisa Benerini Gatta, Piera Balzarini, (unknown), Francesco Castelli, P Grigolato	2
11	Application of alternative fixatives to formalin in diagnostic pathology 2012 ·European Journal of Histochemistry ·Luisa Benerini Gatta, (unknown), Piera Balzarini, Santina Castriciano, Rita Paroni, Andrea Verzeletti, Venusia Cortellini, (unknown), P Grigolato	44
12	Diagnostic Implications of L1, p16, and Ki-67 Proteins and HPV DNA in Low-grade Cervical Intraepithelial Neoplasia 2011 ·International Journal of Gynecological Pathology ·Luisa Benerini Gatta, Angiola Berenzi, Piera Balzarini, Enrico Dessy, Francesca Angiero, Giulio Alessandri, Angela Gambino, Piergiovanni Grigolato, Anna Benetti	11
13	High-level detection of gene amplification and chromosome aneuploidy in extracted nuclei from paraffin-embedded tissue of human cancer using FISH: a new approach for retrospective studies 2009 ·European Journal of Histochemistry ·Elisa Rossi, Alessandro Ubiali, Piera Balzarini, (unknown), (unknown), (unknown)	5
14	Percutaneous coronary injection of bone marrow cells in small experimental animals: Small is not too small 2007 ·Pathology - Research and Practice ·Gabriella Agnoletti, Anna Cargnoni, Laura Agnoletti, (unknown), Piera Balzarini, (unknown), (unknown), Pier Giovanni Grigolato, Roberto Ferrari	1
15	Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion 2005 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Claudio Sorio, Paola Capelli, Daniele Lissandrini, Patrick S. Moore, Piera Balzarini, Massimo Falconi, Giuseppe Zamboni, Aldo Scarpa	17
16	A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 2004 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Claudio Sorio, Patrick S. Moore, Maria Grazia Ennas, Cristina Tecchio, Antonio Bonora, Silvia Sartoris, Piera Balzarini, Piergiovanni Grigolato, Aldo Scarpa	10
17	Chromosome changes in sarcomatoid renal carcinomas are different from those in renal cell carcinomas 2002 ·Cancer Genetics and Cytogenetics ·Paola Dal Cin, Raf Sciot, Hendrik Van Poppel, Piera Balzarini, Tania Roskams, Herman Van den Berghe	18
18	Involvement of Chromosomes 1 and 18 in Renal Cell Tumors 2000 ·Cancer Genetics and Cytogenetics ·Paola Dal Cin, Tania Roskams, Rita De Vos, Hendrik Van Poppel, Piera Balzarini, (unknown)	5
19	Histology May Depend on the Presence of Partial Monosomy or Partial Trisomy 3 in Renal Cell Carcinoma 1998 ·Cancer Genetics and Cytogenetics ·Piera Balzarini, Paola Dal Cin, Tania Roskams, Pietro Polito, (unknown), Boudewijn Van Damme, Luc Baert, (unknown)	9
20	Enzyme‐assisted Cell Photosensitization: A Proposal for an Efficient Approach to Tumor Therapy and Diagnosis. The Rose Bengal Fluorogenic Substrate 1997 ·Photochemistry and Photobiology ·Giovanni Bottiroli, Anna Cleta Croce, Piera Balzarini, Davide Locatelli, Piero Baglioni, Pierandrea Lo Nostro, Monica Monici, Riccardo Pratesi	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact